SCHEMBL6926040

SCHEMBL6926040

OCCOCCNCCOc1cccc2c1c1ccccc1n2Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 8/20 0.47
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
CYP19A1 P11511 1/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
MCL1 Q07820 1/20 0.41
UTS2R Q9UKP6 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
DRD2 P14416 1/20 0.40
HTR1A P08908 2/20 0.40
ADRA1D P25100 2/20 0.40
ADRA1A P35348 2/20 0.40
ADRA1B P35368 2/20 0.40
PLA2G2A P14555 1/20 0.40
P2RX4 Q99571 1/20 0.39
BCHE P06276 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6928704 0.92 HTR1D (0.54) HTR6HTR1DHTR1BCYP19A1KMT2A
SCHEMBL6925529 0.90 HTR6 (0.47) HTR6HTR1DHTR1BCYP19A1KMT2A
SCHEMBL6927462 0.88 HTR6 (0.46) HTR6HTR1DHTR1BCYP19A1KMT2A
SCHEMBL6921654 0.85 HTR6 (0.49) HTR6HTR1BCYP19A1KMT2AUTS2R
SCHEMBL6925119 0.85 HTR1B (0.54) HTR6HTR1BCYP19A1KMT2AMCL1
SCHEMBL6921216 0.84 HTR1B (0.53) HTR6HTR1BCYP19A1KMT2AMEN1
SCHEMBL7508285 0.83 HTR6 (0.45) HTR6CYP19A1MCL1UTS2RKDM4E
SCHEMBL6924730 0.82 KMT2A (0.50) HTR6CYP19A1KMT2AMCL1UTS2R
SCHEMBL6926844 0.82 KMT2A (0.50) HTR6CYP19A1KMT2AMCL1UTS2R
SCHEMBL6924418 0.82 HTR1B (0.51) HTR6HTR1DHTR1BCYP19A1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US claimed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP claimed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO claimed
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed